Differential Diagnosis for Hypercalcemia and Low PTH
Single Most Likely Diagnosis
- Malignancy-associated hypercalcemia: This is often the most common cause of hypercalcemia with low parathyroid hormone (PTH) levels, particularly in patients with known cancer. Malignancies can produce parathyroid hormone-related protein (PTHrP), which mimics the action of PTH, leading to hypercalcemia.
Other Likely Diagnoses
- Vitamin D intoxication: Excessive intake of vitamin D can lead to increased absorption of calcium from the gut, resulting in hypercalcemia. PTH levels are typically low due to negative feedback.
- Familial hypocalciuric hypercalcemia (FHH): Although PTH levels might be in the normal or slightly elevated range, FHH can sometimes present with low PTH due to the set point for PTH secretion being altered. It's a genetic disorder affecting calcium sensing.
- Lithium therapy: Lithium can increase PTH secretion, but in some cases, especially with long-term use, it might lead to a state where PTH levels are not appropriately elevated in response to hypercalcemia, or the hypercalcemia is due to other mechanisms.
Do Not Miss Diagnoses
- Primary hyperparathyroidism with assay interference: Although less likely given the low PTH, some assays might be interfered with by certain antibodies or other substances, leading to falsely low readings. It's crucial to consider this, especially if clinical suspicion for primary hyperparathyroidism is high.
- Hypercalcemia of malignancy with PTHrP production and assay interference: Similar to the above, if a malignancy is producing PTHrP, which is not detected by the standard PTH assay, this could lead to a false diagnosis of low PTH.
Rare Diagnoses
- Williams syndrome: A genetic disorder that can lead to hypercalcemia due to elastin gene deletion affecting calcium metabolism. PTH levels can be low due to the complex pathophysiology of the syndrome.
- Jansen's metaphyseal chondrodysplasia: A rare genetic disorder characterized by hypercalcemia and low PTH due to constitutive activation of the PTH receptor, leading to an abnormal regulation of calcium metabolism.
- Neonatal severe hyperparathyroidism: Although typically presents with high PTH, in some genetic forms, the regulation of PTH and calcium can be so disrupted that it presents with hypercalcemia and inappropriately low PTH levels due to receptor desensitization or other mechanisms.